Schroder Investment Management Group Buys 936,471 Shares of Henry Schein, Inc. $HSIC

Schroder Investment Management Group lifted its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 149.3% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 1,563,899 shares of the company’s stock after buying an additional 936,471 shares during the period. Schroder Investment Management Group’s holdings in Henry Schein were worth $114,243,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of HSIC. Alliancebernstein L.P. raised its stake in shares of Henry Schein by 21.9% during the first quarter. Alliancebernstein L.P. now owns 218,340 shares of the company’s stock valued at $14,954,000 after acquiring an additional 39,188 shares during the last quarter. Great Lakes Advisors LLC purchased a new position in Henry Schein during the 1st quarter valued at about $4,477,000. Atria Investments Inc purchased a new position in Henry Schein during the 2nd quarter valued at about $458,000. K.J. Harrison & Partners Inc raised its position in Henry Schein by 50.0% during the 2nd quarter. K.J. Harrison & Partners Inc now owns 30,000 shares of the company’s stock valued at $2,192,000 after purchasing an additional 10,000 shares during the last quarter. Finally, Brandywine Global Investment Management LLC lifted its holdings in Henry Schein by 5.4% in the 2nd quarter. Brandywine Global Investment Management LLC now owns 79,102 shares of the company’s stock worth $5,778,000 after buying an additional 4,061 shares during the period. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Down 0.8%

NASDAQ:HSIC opened at $74.66 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. The firm’s 50-day moving average price is $67.74 and its 200-day moving average price is $69.40. The company has a market capitalization of $8.79 billion, a PE ratio of 24.08, a P/E/G ratio of 2.06 and a beta of 0.84. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, November 4th. The company reported $1.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.11. The company had revenue of $3.34 billion during the quarter, compared to analysts’ expectations of $3.28 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. On average, equities analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Wall Street Zen upgraded Henry Schein from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. UBS Group cut their price target on shares of Henry Schein from $75.00 to $70.00 and set a “neutral” rating on the stock in a report on Wednesday, August 6th. Morgan Stanley upped their price objective on shares of Henry Schein from $55.00 to $58.00 and gave the stock an “underweight” rating in a report on Wednesday, November 5th. Barrington Research set a $79.00 target price on shares of Henry Schein and gave the company an “outperform” rating in a research note on Wednesday, November 5th. Finally, Evercore ISI increased their price target on shares of Henry Schein from $83.00 to $90.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 5th. Five research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $76.08.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.